Mutations occurring in cytoplasmic molecules, such as tyrosine kinase domains of receptors, KRAS2, PI3KCA, and BRAF [3], could be related to the inflammatory signaling cascades leading to cancer initiation if they occur before the advent of cancer stem cells. This evidence concerns the gene BRAF and cancer.